GTC Biotherapeutics (fka GTCB)

[stockdak]

So the two things from this announcement that jump out at me are that:
1.) GTCB may have saved the FDA fee of $1,178,000 with Orphan drug status. That is not a small amount to this company.
2.) The time line for top-end data just slipped into Jan. 08 from end of 2007.

I am looking for an announcement in early January on the top-line data now as before I was hoping for something before XMAS.

If this is the case I would not be surprised to see the PPS drift lower as it did today.

The open question is will the partnership come through before the top-line data is made public. They did project revenue in the 4th quarter from a such a partner in the last CC. Maybe this projection has slipped as well?

IMO as each day passes toward the end of the year without a partner the downward pressure on the PPS will continue.

I have funds to add to my share count but am betting that we drift lower through the next week before XMAS without a partner announcement.

DAK